高级检索
当前位置: 首页 > 详情页

MiR-33b-5p sensitizes gastric cancer cells to chemotherapy drugs via inhibiting HMGA2 expression

文献详情

资源类型:
机构: [1]Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hengyang, Hunan, Peoples R China [2]Univ South China, Inst Biol Res, Hengyang, Hunan, Peoples R China [3]Univ South China, Canc Res Inst, Hengyang, Hunan, Peoples R China [4]Univ South China, Inst Pharm & Pharmacol, Hengyang, Hunan, Peoples R China
出处:
ISSN:

关键词: MiR-33b-5p HMGA2 chemo-sensitivity gastric cancer

摘要:
MicroRNAs (miRNAs) are internal, non-coding, and similar to 22nt small RNAs that display cell- and tissue-specific expression. They play important regulatory roles in cell proliferation and chemo-sensitivity. This study focused on tumor-suppressive miR-33b-5p expression as well as its role in gastric cancer. MiR-33b-5p was found low expression in gastric cancer cell lines. Functionally, western blots and the luciferase reporter assay were used to confirm that HMGA2 was the potential target of miR-33b-5p. Next, we used CCK-8 kits to analyze the effect of miR-33b-5p combined chemotherapy drugs on cell inhibition rate, and flow cytometry to analyze cells apoptosis. Colony formation ability was determined by plating at 500 cells per well into six-well plates and culturing for 15d. The results showed that upregulation of miR-33b-5p decreased expression of HMGA2 and inhibited gastric cancer cell growth as well as sensitized gastric cancer cells to chemotherapy drugs. MiR-33b-5p overexpression hindered luciferase activity of HMGA2,3-untranslated region-based reporter construct in 293T cells. These data demonstrate that miR-33b-5p may be a potential therapeutic target for gastric cancer and function as tumor-suppressive miRNA through targeting HMGA2 in gastric cancer.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 3 区 医学
小类 | 3 区 药学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 药学
第一作者:
第一作者机构: [1]Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hengyang, Hunan, Peoples R China [2]Univ South China, Inst Biol Res, Hengyang, Hunan, Peoples R China
通讯作者:
通讯机构: [1]Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hengyang, Hunan, Peoples R China [3]Univ South China, Canc Res Inst, Hengyang, Hunan, Peoples R China [4]Univ South China, Inst Pharm & Pharmacol, Hengyang, Hunan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46667 今日访问量:3 总访问量:3332 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号